Literature DB >> 18336013

Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionization-time-of-flight mass spectrometry.

Aldo Polettini1, Rossella Gottardo, Jennifer Paola Pascali, Franco Tagliaro.   

Abstract

Electrospray ionization (ESI)-time-of-flight (TOF) MS enables searching a wide number of pharmaco/toxicologically relevant compounds (PTRC) in biosamples. However, the number of identifiable PTRC depends on extension of reference database of chemical formulas/compound names. Previous approaches proposed in-house or commercial databases with limitations either in PTRC number or content (e.g., few metabolites, presence of non-PTRC). In the frame of development of a ESI-TOF PTRC screening procedure, a subset of PubChem Compound as reference database is proposed. Features of this database (approximately 50,500 compounds) are illustrated, and its performance evaluated through analysis by capillary electrophoresis (CE)-ESI-TOF of hair/blood/urine collected from subjects under treatment with known drugs or by comparison with reference standards. The database is rich in parent compounds of pharmaceutical and illicit drugs, pesticides, and poisons and contains many metabolites (including about 6000 phase I metabolites and 180 glucuronides) and related substances (e.g., impurities, esters). The average number of hits with identical chemical formula is 1.82 +/- 2.27 (median = 1, range 1-39). Minor deficiencies, redundancies, and errors have been detected that do not limit the potential of the database in identifying unknown PTRC. The database allows a much broader search for PTRC than other commercial/in-house databases of chemical formulas/compound names previously proposed. However, the probability that a search retrieves different PTRC having identical chemical formula is higher than with smaller databases, and additional information (anamnestic/circumstantial data, concomitant presence of parent drug and metabolite, selective sample preparation, liquid chromatographic retention, and CE migration behavior) must be used in order to focus the search more tightly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336013     DOI: 10.1021/ac800071n

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

1.  HPLC/APCI-FTICR-MS as a tool for identification of partial polar mutagenic compounds in effect-directed analysis.

Authors:  Mahmoud Bataineh; Urte Lübcke-von Varel; Heiko Hayen; Werner Brack
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-12       Impact factor: 3.109

2.  Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.

Authors:  Fessessework Guale; Shahriar Shahreza; Jeffrey P Walterscheid; Hsin-Hung Chen; Crystal Arndt; Anna T Kelly; Ashraf Mozayani
Journal:  J Anal Toxicol       Date:  2012-11-01       Impact factor: 3.367

3.  Accurate determination of tissue steroid hormones, precursors and conjugates in adult male rat.

Authors:  Naoyuki Maeda; Emi Tanaka; Tomokazu Suzuki; Kanako Okumura; Sachiko Nomura; Taku Miyasho; Satoko Haeno; Hiroshi Yokota
Journal:  J Biochem       Date:  2012-10-10       Impact factor: 3.387

4.  Screening of polycyclic polyprenylated acylphloroglucinols from Garcinia species using precursor ion discovery (PID) scan and ultra performance liquid chromatography electrospray ionization Q-TOF tandem mass spectrometry.

Authors:  Yan Zhou; Sheng-Xiong Huang; Jing-Zheng Song; Chun-Feng Qiao; Song-Lin Li; Quan-Bin Han; Hong-Xi Xu
Journal:  J Am Soc Mass Spectrom       Date:  2009-07-01       Impact factor: 3.109

5.  Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS.

Authors:  Iltaf Shah; Andrea Petroczi; Martina Uvacsek; Márta Ránky; Declan P Naughton
Journal:  Chem Cent J       Date:  2014-12-13       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.